Nothing Special   »   [go: up one dir, main page]

Albert et al., 1993 - Google Patents

SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity

Albert et al., 1993

Document ID
16080502497254818419
Author
Albert R
Marbach P
Bauer W
Briner U
Fricker G
Brums C
Pless J
Publication year
Publication venue
Life sciences

External Links

Snippet

To obtain orally active octreotide (Sandostatin®, SMS 201-995) analogs a new class of glycated somatostatin derivatives were synthesized by the Amadori reaction (Maillard reaction). The synthesis, chemical and biological characterization of a series of new …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Melanocyte-stimulating hormone [MSH] alpha-Melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus

Similar Documents

Publication Publication Date Title
Albert et al. SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity
Grossman et al. Responses to analogues of growth hormone‐releasing hormone in normal subjects, and in growth‐hormone deficient children and young adults
JP2882679B2 (en) Linear somatostatin analog
Veber et al. A super active cyclic hexapeptide analog of somatostatin
Pless et al. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin
CN112409460B (en) GLP-1/glucagon receptor dual agonist and application thereof
US5124314A (en) Pharmaceutical compositions containing amylin
US20090023646A1 (en) GHRH analogues
US5175145A (en) Treatment of diabetes mellitus with amylin agonists
ES2328579T3 (en) LONG-TERM INSULIN DERIVATIVES AND ASSOCIATED PROCEDURES.
Taminato et al. Synthetic gastric inhibitory polypeptide stimulatory effect on insulin and glucagon secretion in the rat
BRPI0413276B1 (en) Insulin derivative, zinc complex thereof, and pharmaceutical composition
US6610649B2 (en) Insulin C-peptides
Lederis et al. Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides
Schick et al. An intragastric meal releases the putative satiety factor cholecystokinin from hypothalamic neurons in cats
US5633263A (en) Linear somatostatin analogs
MURPHY et al. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs
NO174809B (en) Analogous Method for Preparation of Therapeutically Active Octapeptide
US4430326A (en) Method of diminishing glucose levels resulting from endogenous glucagon
Scarpignato Somatostatin analogues in the management of endocrine tumors of the pancreas
Lien et al. Prolonged suppression of insulin release by a somatostatin analog
Lien et al. Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog
US5135912A (en) Natriuretic peptides from the pituitary prohormone proopiomelanocortin
CN115960258B (en) GLP-1/glucon/Y 2 Receptor triple agonists and uses thereof
CN116162147B (en) Long-acting insulin analogue